Indiana University Health Hospital

Indianapolis, Indiana 46202

0 studies enrolling now · 40 studies all time

What they study most

ATTR Amyloidosis With Cardiomyopathy, Adenocarcinoma of the Breast, Advanced Solid Tumors, Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Amyloidosis, Arthralgia, BRAF V600E-mutant Metastatic Colorectal Cancer, Bone Cancer, Brain Cancer, Brain Metastases, Brain Tumor, Breast Cancer

Studies at this site

• Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion — Running, not enrolling
• Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer — Running, not enrolling
• Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region — Completed
• ESWL Versus SOPIL for Treatment of Pancreatic Duct Stones — Completed
• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
• Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer — Completed
• Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma — Stopped early
• Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study — Stopped early
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed
• Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer — Completed
• Pre-operative Stereotactic Radiosurgery Followed by Resection for Patients With Brain Metastases — Completed
• Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases — Stopped early
• Pre-Operative Radiation and Veliparib for Breast Cancer — Completed
• Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With Cardiomyopathy — NO_LONGER_AVAILABLE
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer — Completed
• Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers — Completed
• Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions — Completed
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early
• Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung — Stopped early
• A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes — Completed
• M8891 First in Human in Solid Tumors — Stopped early
• Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers — Completed
• SABR for T1-2a N1 NSCLC — Withdrawn before enrolling
• Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant — Withdrawn before enrolling
• Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation — Completed
• Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy — Completed
• Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancer — Completed
• Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation — Completed
• Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor — Completed
• Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma — Stopped early
• Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma — Completed
• iMETX (Individualized Metabolic RX): a Pilot Study — Completed
• Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors — Stopped early
• Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias — Withdrawn before enrolling
• Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin — Completed
• Impact of LOFT Therapy™ on Breast Cancer Survivors — Completed
• Understanding the Molecular and Genetic Differences Between Germ Cell Tumor at the Time of the Initial Diagnosis and at Late Relapse — Completed
• Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis — Stopped early
• Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML — Stopped early